| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |